The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Reclassification 2026: What It Means for Providers BPC 157 & TB 500: What You Need to Know longevity with peptide therapy BPC 157 + TB500: The Peptide Duo for Next Level Healing Blog Saving Face Austin